Hallucinogens

(See: Drugs in American Society, 5th, 6th, 7th, 8th, and 9th editions, Erich Goode, McGraw-Hill, 1999/2005/2008/2012/2014. Chapters 1/9/10 and Drugs, Society, and Human Behavior, Ray and Ksir, Mosby, 1999. Chapter 15 (8th ed.) Statistics are gathered from the various surveys discussed, especially: Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.

(Hey, don't stare at this too long!)

Try Wow, too. (or this)

Ancient Religions

What's in a Name?

WWW Links


General Categories of Hallucinogens


Indole Hallucinogens


LSD

LSD-25 (this .zip file is a program to download (it will need to be unzipped!) that will give you a taste of the experience!  Contact viehland@umr.edu for more information.

In addition to ergotamine and dihydroergotamine which are used in the treatment of migraines, the ergot alkaloid methylergonovine is an obstetric agent used to induce labor and to control excessive uterine bleeding. (I believe these are it’s main uses; I’m a psychiatrist so that’s not the usual end of the body that I treat.) Also, if I’m not mistaken, Hydergine (ergoloid mesylate) is also a related compound believed by some to improve cognitive ability.

The ergot preparations used in migraine therapy are potent vasoconstrictors and are metabolized in the liver by a specific subset (3A) of metabolic enzymes (known as the cytochrome P450 system). Among the antiretroviral protease inhibitors, ritonavir and indinavir are particularly potent inhibitors of the cytochrome P450 3A subset (among others). I have run across 3 case reports in which migraine treatment with ergotamine resulted in severe systemic vasoconstriction when co-administered with indinavir or ritonavir. According to the PDR, "ergotamine overdose [may] include the following: numbness, tingling, pain, and cyanosis of the extremities associated with diminished or absent peripheral pulses; respiratory depression; an increase and/or decrease in blood pressure, usually in that order; confusion, delirium, convulsions, and coma; and/or some degree of nausea, vomiting, and abdominal pain." For dyhydroergotamine the maximum recommended dose is no more than 4mg administered intranasally over the course of 7 days (in 0.5mg doses) and for ergotamine no more than 10mg (in 1mg doses) over the course of a week. Overt ergotism is rare but apparently may be precipitated by the inhibition of hepatic metabolism of these 2 drugs.

I have found no references to adverse reactions to Hydergine or methylergonovine in combination protease inhibitors or other cytochome P450 inhibitors (two common examples being nefazodone and erythromycin). Additionally there are no reports of adverse reactions to LSD in individuals taking cyp3A inhibitors. Appologies for the confusion regarding which drugs I was referring to in the phrase "these agents" near the end of my previous post.

David Gillenwater, M.D. dgillen@emory.edu

Emory University School of Medicine

Department of Psychiatry and Behavioral Health

HIV/AIDS Clinical Research Training Program

Albert Hofmann

Albert Hoffmann Dies: April 30, 2008

  1. 1938: Albert Hofmann (Albert Hofmann Foundation) synthesizes LSD at Sandoz Laboratories
  2. April 16, 1943: Hofmann accidentally absorbs a tiny bit through his skin. The first "trip," about 3 hours in duration.
  3. "An uninterrupted stream of fantastic images of extraordinary plasticity...accompanied by an intense, kaleidoscope-like play of colors."
  4. April 19, 1943: Hofmann deliberately ingests 250 micrograms. Experiences anxiety, but is fine the next day (bicycle day)(2013).
  5. 1947: Werner Stoll reports on the mental effects of LSD
  6. 1952: Charles Savage reports on the first use of LSD to treat depression
  7. 1953: LSD clinic opens in England- Roland Sadison. In USA, CIA's Project MK-Ultra. An account of other CIA testing,
  8. 1955: Conference on LSD and Mescaline in USA
  9. 1960: Harvard's Timothy Leary establishes the Psychedelic Research Project.
  10. 1960's Army experimentation. (account)(local copy)
  11. 1963: First year LSD is recorded on the streets. Sugar cubes. Media coverage. Leary fired.
  12. 1966: Government bans LSD.
  13. 1967: First "human be-in" held in San Francisco. "Summer of Love"
  14. 1970: Dock Ellis no-hitter for the Pirates
  15. 1975: End of formal research
  16. 1976: "Blotter Acid" emerges as primary type.
  17. 1979: Hofmann publishes, "LSD: My Problem Child."
  18. 1988: Re surfacing of the "psychedelic movement." Rave scene.
  19. 2005: Re-evaluation of the therapeutic potential of LSD

line

LSD's Long, Strange Trip (NY Times Retro Report 5/17/16: http://nyti.ms/23TmwIW)
(transcript)


http://www.nytimes.com/video/us/100000004406557/lsds-long-strange-trip.html


Blotter Acid Art

More Images from Erowid


LSD and Psychiatry (John Neill)

  1. Methodology: subjective vs objective
  2. Distinction between therapist and patient? Therapist use of the drug.
  3. Unpredictability of effects

LSD and Therapy

DrugsText information sheet on LSD

We'll Be Back. LSD has a way of "doing that!"


Psilocybin

"It permits you to travel backwards and forward in time, to enter other planes of existence. Even (as the Indians say), to know God..."


Morning Glory (faq)


DMT

DrugsText Information on DMT



Catechol Hallucinogens


Mescaline

Pharmacology

Religious Use

Non-Religious Use



Amphetamine derivatives


DOM


MDA

(see also DrugText for additional information)


MDMA 


(Photo from Erowid: http://www.erowid.org/)


Nutmeg

Anticholinergic Hallucinogens


Belladonna

Mandrake

Henbane

Datura

Synthetic Anticholinergics



Amanita Muscaria



PCP

See also: Ketamine ("Special K," "Vitamin K"): Effects


And There's More:

Plants:

Synthetics:

And:


LSD: Focus

Subjective effects

Objective Effects

Latter two seem to reflect use patterns and subcultural controls. As use has remained consistent, perhaps even slight increase; problems associated with use have decreased.


Becker on Subculture

Goode


Chronic Objective Effects

  1. 1967: Chromosome breaks. Tetragenesis (leads to birth defects). Thalidomide scare.
  2. Heavy Press coverage, distortions: "Acid Burned a Hole in My Genes"
  3. Problem of controls in the studies: Street vs Pure drug; Frequency and dosage levels, Other drugs, Animal studies vs. Humans
  4. And, chromosome breakage does not mean birth defects: "normal" rate is about 4%. Question is, is the rate significantly higher for mothers who take LSD. And, when did she? First trimester is most critical
  5. Major studies suggest that impurities in street acid seem to explain problems.
  6. Mutagenesis is related to massive doses, Pure LSD does not appear to be significantly related to birth defects
  7. Politics and Ideology
  8. In 2000, LSD accounted for .01% of DAWN ER cases
  9. Subcultural change, as well as media hype.
  10. Yet, early media attention was instrumental force in passing Drug Abuse Control Act of 1966 (which leveled controls on LSD). By 1970: Controlled Substances Act.


Use Patterns
(Statistics are gathered from the various surveys discussed, especially: Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.)

1967

1969

1972

1979

1%

4%

5%

maybe 20-25% (18-25 year olds)

2013

Hallucinogens

LSD

Lifetime

15.1%

9.4%

Past Year

1.7%

.4%

Past Month

.5%

.1%

NSDUH 2003-2013, 12 years of age and older (percentages)

  03 life 04 life 09 life 12 life 13 life 03 year 04 year 09 year 12 year 13 year 03 month 04 month 09 month 12 month 13 month
Hallucinogens
14.5
14.3
14.8
14.6
15.1
1.7
1.6
1.8
1.7
1.7
.4
.4
.5
.4
.5
LSD
10.3
9.7
9.4
9.1
9.4
.2
.2
.3
.4
.4
.1
.1
.1
.1
.1
PCP
3
2.8
2.5
2.5
2.5
.1
.1
.0
.0
0
.0
.0
.0
.0
0
Ecstasy
4.6
4.6
5.7
6.2
6.8
.9
.8
1.1
1.0
1.0
.2
.2
.3
.2
.3



CNS Stimulants: Xanthines, Amphetamine, Nicotine, and Cocaine


URL: http://www.umsl.edu/~keelr/180/hallucin.html
Owner: Robert O. Keel rok@umsl.edu
References and Credits for this Page of Notes
Last Updated: Tuesday, November 10, 2020 10:22 AM